Search clinical trials for: Ocriplasmin 125µg

Total 72 results

ThromboGenics

Completed

A Study of the Safety and Efficacy of Microplasmin to Induce a Posterior Vitreous Detachment (MIVI III)

Vitrectomy

United States
ThromboGenics

Completed

Trial of Microplasmin Intravitreal Injection for Non-Surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-007) Trial.

Vitreomacular Adhesion

United States, Spain, United Kingdom, Germany, Belgium, Czech Republic, Poland
Universitaire Ziekenhuizen KU Leuven
KU Leuven

Completed

Phase I RVC With Ocriplasmin for CRVO (RVC_CRVO)

Central Retinal Vein Occlusion

Belgium
ThromboGenics

Completed

Follow-up Study to Assess Visual Function in Subset of Patients Who Have Previously Participated in the TG-MV-006 and TG-MV-007 Ocriplasmin Studies

Symptomatic Vitreomacular Adhesion

United States, Belgium
ThromboGenics

Completed

Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole (OASIS)

Vitreomacular Adhesion Including Macular Hole

United States
ThromboGenics

Completed

Safety and Efficacy Study of Intravitreal Ocriplasmin in Subjects With AMD With Focal Vitreomacular Adhesion (MIVI-5)

Exudative Age-Related Macular Degeneration | Focal Vitreomacular Adhesion

United States, United Kingdom, Germany, France, Belgium, Italy
Alcon Research

Completed

A Phase III Study of A01016 in Subjects With Symptomatic Vitreomacular Adhesion

Symptomatic Vitreomacular Adhesion

Japan
ThromboGenics

Terminated

A Study to Evaluate the Efficacy and Safety of Ocriplasmin in Inducing Total PVD in Subjects With NPDR (CIRCLE)

Disease Progression | Diabetic Retinopathy | Posterior Vitreous Detachment

United States, Czechia, United Kingdom, France, Germany, Hungary, Spain, Israel, Italy
ThromboGenics

Completed

Clinical Trial of Intravitreal Microplasmin in Infants and Children Scheduled for Vitrectomy (MIC)

Vitrectomy

United States
Alcon Research

Completed

Assessment of Patients Treated With JETREA® for Vitreomacular Traction

Vitreomacular Traction | Vitreomacular Adhesion
Alcon Research

Completed

Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular Adhesion

Vitreomacular Traction | Vitreomacular Adhesion

Australia
Ordination Dr. Hommer

Completed

A Study on the Effect of Changing From Preserved Prostaglandin Formulations to Preservative Free Tafluprost on Tear Film Thickness

Ocular Hypertension | Glaucoma, Open-Angle

Austria
Napo Pharmaceuticals, Inc.

Completed

Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in HIV+ Patients With Non-Infectious Diarrhea

Acquired Immunodeficiency Syndrome | HIV/AIDS | Healthy Volunteers | Human Immunodeficiency Virus | HIV Diarrhea

United States
ThromboGenics

Completed

Trial of Microplasmin Intravitreal Injection for Non-surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-006) Trial.

Vitreomacular Adhesion

United States
ThromboGenics

Completed

The Purpose of This Study is to Evaluate the Pharmacokinetic Properties of Intravitreal Ocriplasmin Prior to Planned Primary Pars Plana Vitrectomy (PPV) (MIVI-10)

Vitrectomy

Belgium
The Affiliated Hospital of Qingdao University

Completed

Bioequivalence of Cefprozil Granule in Healthy Chinese Volunteers

Healthy Volunteers

China
The Affiliated Hospital of Qingdao University

Completed

A Phase I Clinical Study on SHR6390 in Healthy Chinese Volunteers

Healthy Volunteers

China
ThromboGenics

Completed

A Multicenter Study to Compare Multiple Doses of Intravitreal Microplasmin Versus Sham Injection for Treatment of Patients With Diabetic Macular Edema (DME) (MIVI-II)

Diabetic Macular Edema

Spain, Belgium, United Kingdom, Italy, Netherlands, Germany
ThromboGenics

Completed

A Study to Compare Multiple Doses Intravitreal Microplasmin for Treatment of Patients With Vitreomacular Traction (MIVI-IIt)

Vitreomacular Traction

Belgium, Germany
Merck Sharp & Dohme LLC

Completed

A Single and Multiple-Dose Study of MK-8521 in Healthy and Obese Males (MK-8521-002)

Type 2 Diabetes Mellitus
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Not yet recruiting

A Safety and Immunogenicity Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 50 to 70 Years

Herpes Zoster

Australia
University of Karachi
Merck (Pvt.) Limited, Pakistan; Center for Bioequivalence Studies and Clinical...

Completed

Bioequivalence Study of Klaribact 125mg/5ml, Suspension (BE)

Healthy

Pakistan
Sahlgrenska University Hospital, Sweden
Danone Research

Completed

Effects of Activia in IBS (MOSAIC)

Irritable Bowel Syndrome

Sweden
Johns Hopkins University
National Institute on Aging (NIA)

Completed

Levetiracetam and Memory Function in Amnestic Mild Cognitive Impairment (MCI)

Mild Cognitive Impairment (MCI)

United States
University of Nebraska

Recruiting

Clinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine Therapy

Breast Cancer

United States
Zealand University Hospital

Recruiting

Prophylactic Antibiotic Treatment in Hemodialysis (PANTHEM)

Hemodialysis

Denmark
Shaheer A. Khan
AstraZeneca; Melanoma Research Alliance

Completed

Intermittent Selumetinib for Uveal Melanoma

Uveal Melanoma

United States
Megalabs

Not yet recruiting

Bioequivalence Study of Palbociclib 125 mg Capsules of Iclos vs. Ibrance (Palbociclib) Capsules 125 mg

Bioequivalence
Geropharm

Completed

Bioequivalence Study of Bosentan 125 mg Tablets Immediate Release (IR) Versus Tracleer® 125 mg Tablets IR In Healthy Subjects

Bioequivalence

Russian Federation
Memorial Sloan Kettering Cancer Center
Pfizer

Completed

PD0332991 (Palbociclib) in Patients With Advanced or Metastatic Liposarcoma

Sarcoma | Liposarcoma

United States
Namik Kemal University

Not yet recruiting

Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?

Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors

Turkey
Razelle Kurzrock, MD

Withdrawn

Histology-Independent Study of Palbociclib in Patients With Advanced Cancer

Cancer, Advanced

United States
CrystalGenomics, Inc.

Completed

Pharmacokinetics and Safety of 'CG-745 IV' and 'CG-750' in Healthy Male Adults

Healthy

Korea, Republic of
Yale University
Alzheimer's Therapeutic Research Institute

Completed

A Phase IIa Multi-Center Study of 18F-FDG PET, Safety, and Tolerability of AZD0530 in Mild Alzheimer's Disease

Alzheimer's Disease

United States, Canada
Xuzhou Medical University

Unknown

the Effect of Tracleer on Tourniquet-associated Hypertension

Hypertension | Tourniquets | Bosentan

China
Pfizer

Completed

A Study To Investigate Palbociclib (PD-0332991) Pharmacokinetics In Healthy Subjects Of Japanese Descent Relative To Healthy Non-Asian Subjects, And To Determine If Changes In Palbociclib Dose Result In Proportional Changes In Palbociclib Plasma Exposure In Japanese Subjects

Healthy

United States
MEDA Pharma GmbH & Co. KG
ClinResearch, GmbH; Trio Clinical Research, LLC, Raleigh, USA; NuCara Pharmacy... and other collaborators

Completed

Relative Potency of Formoterol Novolizer® 12 µg Compared to Formoterol Aerolizer® 12 µg

Asthma

United States
Chang Gung Memorial Hospital

Recruiting

Dose Escalation and Dose Expansion Study of GAS in Subjects With Metastatic Pancreatic Adenocarcinoma (GAS)

Metastatic Pancreatic Adenocarcinoma

Taiwan
Hiroshima University
CHUGOKU KAYAKU CO., LTD.

Completed

Comparison of Absorbability Between Calcium Tablet and Calcium Ion Water

Healthy

Japan
ETOP IBCSG Partners Foundation
Pfizer

Recruiting

Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer (POLAR)

Breast Cancer Recurrent

Switzerland, Italy, France, Spain, Hungary, Austria
University of Michigan Rogel Cancer Center

Withdrawn

Phase IV Multi-arm Study of CDK4/6 Pharmacokinetics in Healthy Volunteers With Known CYP3A4*22 Genotype

CYP3A4*22
Hartford Hospital
Optimer Pharmaceuticals LLC

Completed

Study to Assess Inhibition of Spore Production in Patients With C. Difficile Infections: Fidaxomicin Versus Vancomycin

Clostridium Difficile Infection

United States
Jiangsu Province Centers for Disease Control and...
Third Military Medical University; Chengdu Olymvax Biopharmaceuticals Inc.

Completed

A Study of a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults

Staphylococcus Aureus Infection

China
CHU de Quebec-Universite Laval

Unknown

The Use of Prophylactic Antibiotics in Endoscopy Sinus Surgery for Chronic Rhinosinusitis With or Without Polyp

Chronic Sinus Infection

Canada
Idelberto Badell
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Subcutaneous Abatacept in Renal Transplant Recipients (RTB-016)

Kidney Transplant Recipient

United States
Unither Pharmaceuticals, France
AIXIAL Development

Completed

Paracetamol UNIFLASH for Buccal Use Phase III Trial in Acute Pain Due to a Tooth Extraction

Acute Pain

Spain, France, Italy, Poland
Jiangsu Province Centers for Disease Control and...
Third Military Medical University; Chengdu Olymvax Biopharmaceuticals Inc.

Completed

A Clinical Trial to Evaluate a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults

Staphylococcus Aureus Infection

China
Tartu University Hospital
University of Tartu; Estonian Defence Forces

Completed

Vitamin D Supplementation in Estonian Conscripts

Vitamin D Deficiency | Physical Stress | Military Activity

Estonia
Sichuan Provincial People's Hospital

Unknown

Hypofractionated Brain Radiation In EGFR Mutated Adenocarcinoma Cranial Disease (Hybrid) (Hybrid)

Stage IV EGFR Mutated NSCL With Brain Metastases

China
Seoul National University Hospital

Completed

The Impact of Antibiotic Prophylaxis on Incidence of Post-bronchoscopy Fever and Change of Serum Cytokines

Pneumonia | Fever

Search clinical trials for: Ocriplasmin 125µg

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations